Publications

Invasive breast cancer and breast cancer death after non-screen detected ductal carcinoma in situ from 1990 to 2018 in England: population based cohort study.

Mannu GS. et al, (2024), BMJ, 384

Ki67 and breast cancer mortality in women with invasive breast cancer.

Probert J. et al, (2023), JNCI Cancer Spectr, 7

Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort study.

Taylor C. et al, (2023), BMJ, 381

Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials.

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Electronic address: bc.overview@ctsu.ox.ac.uk None. and Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) None., (2023), Lancet, 401, 1277 - 1292

Global economic burden of unmet surgical need for appendicitis.

Reuter A. et al, (2022), Br J Surg, 109, 995 - 1003

Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality.

Kerr AJ. et al, (2022), Cancer Treat Rev, 105

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2022), Lancet Oncol, 23, 382 - 392

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials.

Early Breast Cancer Trialists’ Collaborative group (EBCTCG) None., (2021), Lancet Oncol, 22, 1139 - 1150

Deep EHR Spotlight: a Framework and Mechanism to Highlight Events in Electronic Health Records for Explainable Predictions.

Nguyen-Duc T. et al, (2021), AMIA Annu Symp Proc, 2021, 475 - 484

Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study.

Mannu GS. et al, (2020), BMJ, 369

Twenty five year risks of breast cancer mortality in 500,000 women

Taylor C. et al, (2020), BREAST CANCER RESEARCH AND TREATMENT, 180, 589 - 589

Reliability of preoperative breast biopsies showing ductal carcinoma in situ and implications for non-operative treatment: a cohort study.

Mannu GS. et al, (2019), Breast Cancer Res Treat, 178, 409 - 418

Global variation in anastomosis and end colostomy formation following left-sided colorectal resection.

GlobalSurg Collaborative None., (2019), BJS Open, 3, 403 - 414

ENT MCQs for Medical Students: with explanatory answers

Mannu GS. and Odutoye T., (2019), 1 - 175

Prognostic factors for male breast cancer: A breast center's 10-year experience.

Mannu GS. et al, (2018), Breast J, 24, 1116 - 1117

Role of tamoxifen in idiopathic gynecomastia: A 10-year prospective cohort study.

Mannu GS. et al, (2018), Breast J, 24, 1043 - 1045

Risk factors for upgrading and upstaging of pre-operative biopsies in ductal carcinoma in situ

Mannu GS. et al, (2018), CANCER RESEARCH, 78

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2018), Lancet Oncol, 19, 27 - 39

Closure methods of the appendix stump for complications during laparoscopic appendectomy.

Mannu GS. et al, (2017), Cochrane Database Syst Rev, 11

Making progress in early breast cancer: Taking time or accepting risk?

Mannu GS. and Dodwell D., (2017), Eur J Cancer, 78, 24 - 27

Cookies on this website

Publications